Systemic treatment of advanced esophageal squamous cell carcinoma: chemotherapy, molecular-targeting therapy and immunotherapy
Year: 2019
Type: review
DOI: 10.1093/jjco/hyz034
Authors: Hidekazu Hirano, Ken Kato
Institutions: Keio University, National Cancer Center Hospital
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Keywords: esophageal squamous cell carcinoma, advanced esophageal cancer, systemic therapy, chemotherapy, immunotherapy, PD-1 inhibitors, nivolumab, pembrolizumab, gefitinib, panitumumab, nimotuzumab, predictive biomarkers, immune checkpoint inhibitors, next-generation sequencing, genetic alterations, cisplatin, 5-fluorouracil, irinotecan, oxaliplatin, paclitaxel
Open Access status: closed
OpenAlex ID: W2929886485
